Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on March 13, 2025
EnnoDC presents positive Phase I data at CROI 2025, demonstrating long-lasting immunity induced by Antibody Mediated Vaccines (AMVs)
GlobeNewswire
·
March 13, 2025
EnnoDC presents positive Phase I data at CROI 2025, demonstrating long-lasting immunity induced by Antibody Mediated Vaccines (AMVs) Findings in HIV highlight AMV technology's versatility, robust immune response, and excellent safety profile, underpinning …
Medigene Files Patent for Unique NK-Specific TCR Construct with European Patent Office
GlobeNewswire
·
March 13, 2025
Medigene AG (Medigene, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor (TCR)-guided therapies for the treatment of cancer, today announced the submission of a patent for a novel natural …
Aclarion Provides Shareholder Update
GlobeNewswire
·
March 13, 2025
BROOMFIELD, Colo., March 13, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help …
FDA Issues Clearance for ReWalk 7 Exoskeleton
GlobeNewswire
·
March 13, 2025
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or …
Zeranovia(TM) Weight Loss Product Shows Promising Results in Dosage Trial
GlobeNewswire
·
March 13, 2025
LAS VEGAS, March 13, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives Inc. (OTC: BDPT) today announced the successful completion of dosage trials for its innovative weight loss product, Zeranovia™. The trial demonstrated significant weight loss results …
Salipro Biotech und Boehringer Ingelheim schließen Forschungs- und Lizenzvertrag zur Beschleunigung mehrerer Pipeline-Programme von Boehringer Ingelheim
GlobeNewswire
·
March 13, 2025
STOCKHOLM, March 13, 2025 (GLOBE NEWSWIRE) -- Salipro Biotech AB, ein schwedisches Biotechnologieunternehmen, das sich auf die Stabilisierung anspruchsvoller Wirkstoffziele spezialisiert hat, gab heute einen Forschungs- und Lizenzvertrag mit Boehringer …
Salipro Biotech and Boehringer Ingelheim Enter Research and License Agreement to Accelerate Multiple Boehringer Ingelheim Pipeline Programs
GlobeNewswire
·
March 13, 2025
STOCKHOLM, March 13, 2025 (GLOBE NEWSWIRE) -- Salipro Biotech AB, a Swedish biotech company specialising in the stabilisation of challenging drug targets, today announced a research and license agreement with Boehringer Ingelheim to accelerate the …
Salipro Biotech et Boehringer Ingelheim concluent un accord de recherche et de licence en vue d’accélérer plusieurs programmes du pipeline de Boehringer Ingelheim
GlobeNewswire
·
March 13, 2025
STOCKHOLM, 13 mars 2025 (GLOBE NEWSWIRE) -- Salipro Biotech AB, société suédoise de biotechnologie spécialisée dans la stabilisation de cibles pharmacologiques difficiles à étudier, a annoncé ce jour la conclusion d’un accord de recherche et de licence …
NEXGEL to Participate in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 25-26th, 2025
GlobeNewswire
·
March 13, 2025
LANGHORNE, Pa., March 13, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer …
Solésence Wins Best Prestige Finished Formula at the 2025 Cosmetics & Toiletries Allē Awards, Marking Third Consecutive Win
GlobeNewswire
·
March 13, 2025
ROMEOVILLE, Ill., March 13, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that their market-ready product, Au Lait Face Milk SPF 50 …
Dogwood Therapeutics, Inc. Announces Pricing of $4.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
GlobeNewswire
·
March 13, 2025
Proceeds from today’s financing, when added to existing cash, fund operations through Q1 2026 The Company is planning to announce interim data from its ongoing Halneuron® Phase 2b chemotherapy induced neuropathic pain (“CINP”) trial in Q4 2025 ATLANTA, …
Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML
GlobeNewswire
·
March 13, 2025
In-Motion Webinar: Bionano will host a webinar featuring the study’s lead author, Dr. Guilin Tang, who will discuss the study and its findings in detail, including a summary of the potential implications for wide-spread adoption of optical genome mapping …
The International Myeloma Foundation Announces 2nd Annual Iceland Cycling Expedition, to be Held from August 27 – September 2
GlobeNewswire
·
March 13, 2025
STUDIO CITY, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) is excited to announce that the 2nd annual Iceland Cycling Expedition (ICE)—a 6-night/7-day endurance fundraiser biking expedition —will take place from …
Allarity Therapeutics Announces Final Settlement with the U.S. Securities and Exchange Commission
GlobeNewswire
·
March 13, 2025
Boston (March 13, 2025)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated dual PARP/Wnt pathway inhibitor—today announced that it …
SS Innovations Unveils India’s First Mobile Tele-Surgical Unit at SMRSC 2025
GlobeNewswire
·
March 13, 2025
FORT LAUDERDALE, Fla., March 13, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery …
Femasys Announces FemBloc Delivery System Approval in Europe; A Significant Step Towards FemBloc Permanent Birth Control Availability as the First-Ever Non-Surgical Approach
GlobeNewswire
·
March 13, 2025
ATLANTA, March 13, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic and diagnostic …
Kane Biotech Secures IRB Approval to Launch Innovative DispersinB® Acne Trial
GlobeNewswire
·
March 13, 2025
WINNIPEG, Manitoba, March 13, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) ("Kane Biotech" or "Kane") announces today that it has received approval from the Internal Review Board (“IRB”) of the University of Miami Health System (“ …
Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs
GlobeNewswire
·
March 13, 2025
NYC Building …
Novartis Pharmaceuticals and Folia Health Partner on Innovative App-Based Study to Assess Real-World Experience of IgA Nephropathy
GlobeNewswire
·
March 13, 2025
BOSTON, March 13, 2025 (GLOBE NEWSWIRE) -- Today, Folia Health and Novartis Pharmaceuticals, Inc. proudly announce their collaboration on an innovative, at-home observational real-world evidence initiative supporting individuals with IgA nephropathy. This …
Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award
GlobeNewswire
·
March 13, 2025
WALTHAM, Mass., March 13, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, is …